Skip to content
2000
Volume 13, Issue 3
  • ISSN: 2211-7385
  • E-ISSN: 2211-7393

Abstract

Nano-Structured Lipid Carriers (NLCs) are improved Solid Lipid Nanoparticles (SLNs) that recover the permanency and capacity of drug payload. There are 3 different types of NLCs which have been anticipated. The aforementioned Lipid Nano Particles (LNPs) possess possible tenders in drug delivery systems, cosmeceuticals, clinical research and many others. Here, we highlight the structure, ingredients, different manufacturing techniques and analysis of NLCs which are rudiments in formulating a unique drug delivery system. These types of formulations are therapeutically advantageous like skin hydration, occlusion and improved bioavailability as well as skin targeting. In this article, we have also discussed the features, and novelty of NLCs, different advantages as promising assistance in topical drug delivery systems, shortcomings and utilisations of LNPs by concentrating on NLCs.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/pnt/10.2174/0122117385325593240820044758
2024-08-29
2025-09-25

  • From This Site

    /content/journals/pnt/10.2174/0122117385325593240820044758
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. CharanTejaV.R. A glimpse on solid lipid nanoparticles as drug delivery systems.J. Glob. Trends Pharm. Sci.20145216491657
     [Google Scholar]
  2. TiwariA. RasiS. Sonia Anand Solid lipid nanoparticles as carrier in drug delivery system.World J. Pharm. Pharm. Sci.201548337355
     [Google Scholar]
  3. JawaharN. MeyyanathanS.N. Gowtham Reddy and Sumeet Sood. Solid lipid nanoparticles for oral delivery of poorly soluble drugs.J. Pharmaceut. Sci. Res.20124718481855
     [Google Scholar]
  4. AttamaA.A. MomohM.A. BuildersP.F. Lipid nano particulate drug delivery systems: a revolution in dosage form design and development.Pharmacology, Toxicology and Pharmaceutical Science. SezerA.D. CroatiaInTech Open Access Publisher2012
     [Google Scholar]
  5. KaurJ. SinghG. SainiS. RanaA.C. Innivative growth in developing new methods for formulating solid lipid nanoparticles and microparticles.J. Drug Deliv. Ther.20122510.22270/jddt.v2i5.295
     [Google Scholar]
  6. WaghmareA. GrampurohitN. GadhaveM. GaikwadD. JadhavS. Solid lipid nanoparticles: a promising drug delivery system.Int. Res. J. Pharm201234100107
     [Google Scholar]
  7. DasS. ChaudhuryA. Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery.AAPS PharmSciTech.2011121627610.1208/s12249‑010‑9563‑021174180
     [Google Scholar]
  8. PardeikeJ. HommossA. MüllerR.H. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products.Int. J. Pharm.20093661-217018410.1016/j.ijpharm.2008.10.00318992314
     [Google Scholar]
  9. ThatipamulaR. PalemC. GannuR. MudragadaS. YamsaniM. Formulation and in vitro characterization of domperidone loaded solid lipid nanoparticles and nanostructured lipid carriers.Daru2011191233222615636
     [Google Scholar]
  10. WilliamsA.C. BarryB.W. Penetration enhancers.Adv. Drug Deliv. Rev.200456560361810.1016/j.addr.2003.10.02515019749
     [Google Scholar]
  11. ValentaC. SchultzK. Influence of carrageenan on the rheology and skin permeation of microemulsion formulations.J. Control. Release200495225726510.1016/j.jconrel.2003.11.02014980774
     [Google Scholar]
  12. TiwariS. MistryP. PatelV. SLNs based on co-processed lipids for topical delivery of terbinafine hydrochloride.J. Pharm. Drug Dev.201416604
     [Google Scholar]
  13. VaghasiyaH. KumarA. SawantK. Development of solid lipid nanoparticles based controlled release system for topical delivery of terbinafine hydrochloride.Eur. J. Pharm. Sci.201411223557842
     [Google Scholar]
  14. GabaB. FazilM. KhanS. AliA. SanjulaBaboota, Javed Ali. Nanostructured lipid carrier system for topical delivery of terbinafineHCl.Bull. Fac. Pharm. Cairo Univ.20155314715910.1016/j.bfopcu.2015.10.001
     [Google Scholar]
  15. NatarajanJ. Nanostructured Lipid Carrier (NLC): A Promising Drug Delivery System.Global J. Nanomed.20171516
     [Google Scholar]
  16. KhaterD. NsairatH. OdehF. SalehM. JaberA. AlshaerW. Al BawabA. MubarakM.S. Design, Preparation, and Characterization of Effective Dermal and Transdermal Lipid Nanoparticles: A Review.Cosmetics2021823910.3390/cosmetics8020039
     [Google Scholar]
  17. ButaniD. YewaleC. MisraA. Topical Amphotericin B solid lipid nanoparticles: Design and development.Colloids Surf. B Biointerfaces2016139172410.1016/j.colsurfb.2015.07.03226700229
     [Google Scholar]
  18. ChenJ. WeiN. Lopez-GarciaM. AmbroseD. LeeJ. AnnelinC. PetersonT. Development and evaluation of resveratrol, Vitamin E, and epigallocatechin gallate loaded lipid nanoparticles for skin care applications.Eur. J. Pharm. Biopharm.201711728629110.1016/j.ejpb.2017.04.00828411056
     [Google Scholar]
  19. DesmetE. Van GeleM. LambertJ. Topically applied lipid- and surfactant-based nanoparticles in the treatment of skin disorders.Expert Opin. Drug Deliv.201714110912210.1080/17425247.2016.120607327348356
     [Google Scholar]
  20. LauterbachA. Muller-GoymannCC. Applications and limitations of lipid nanoparticles in dermal and transdermal drug delivery via the follicular route.Eur. J. Pharm. Biopharm.20159715216310.1016/j.ejpb.2015.06.020
     [Google Scholar]
  21. MartoJ. SangalliC. CapraP. PeruginiP. AscensoA. GonçalvesL. RibeiroH. Development and characterization of new and scalable topical formulations containing N-acetyl- d -glucosamine-loaded solid lipid nanoparticles.Drug Dev. Ind. Pharm.201743111792180010.1080/03639045.2017.133908328581831
     [Google Scholar]
  22. KaurP.L. GuleriT.K. Topical gel: a recent approach for novel drug delivery.Asia J. Biomed. Pharmaceut. Sci.201331715
     [Google Scholar]
  23. HaftekM. TeillonM.H. SchmittD. Stratum corneum, corneodesmosomes and ex vivo percutaneous penetration.Microscopy Res. Tech.199843324224910.1002/(SICI)1097‑0029(19981101)43:3<242::AID‑JEMT6>3.0.CO;2‑G
     [Google Scholar]
  24. CevcG. VierlU. Nanotechnology and the transdermal route: A state of the art review and critical appraisal.J. Cont. Release20101413277299
     [Google Scholar]
  25. ValenzuelaP. SimonJ.A. Nanoparticle delivery for transdermal HRT.Nanomedicine20128Suppl. 1S83S8910.1016/j.nano.2012.05.00822640909
     [Google Scholar]
  26. LopesCPA. Development and Characterization of Lipid Nanoparticles prepared by Miniemulsion Technique.Master Thesis, Instituto Superior Técnico, Universidade de Lisboa, Portugal, 2014.
     [Google Scholar]
  27. PeddintiS. Nanostructured lipid carriers as a drug carrier.J PharmNanotechnolNanostruc201646874
     [Google Scholar]
  28. CharcossetC. El-HaratiA. FessiH. Preparation of solid lipid nanoparticles using a membrane contactor.J. Control. Release2005108111212010.1016/j.jconrel.2005.07.02316169111
     [Google Scholar]
  29. JoshiM. PathakS. SharmaS. PatravaleV. Design and in vivo pharmacodynamic evaluation of nanostructured lipid carriers for parenteral delivery of artemether: Nanoject.Int. J. Pharm.2008364111912610.1016/j.ijpharm.2008.07.03218765274
     [Google Scholar]
  30. ShahR. EldridgeD. PalomboE. HardingI. Lipid Nanoparticles: Production, Characterization and Stability.Briefs Pharm Sci Drug Dev20151112310.1007/978‑3‑319‑10711‑0_2
     [Google Scholar]
  31. RadtkeM. MullerR. Nanostructured Lipid Drug Carriers.2001Available from: https://citeseerx.ist.psu.edu/document?repid=rep1&type=pdf&doi=d3cb3f6804d7f1f026b49f5294a7729ca85e7195(accessed on 12-8-2024)
     [Google Scholar]
  32. ZhangH.W. DangQ. ZhangZ.W. WuF.S. Development, characterization and evaluation of doxorubicin nanostructured lipid carriers for prostate cancer.J. BUON201722110211128365942
     [Google Scholar]
  33. RadtkeM. MüllerR.H. Nanostructured Lipid Carriers: A novel generation of solid lipid drug drug Carriers.Pharmaceutical Technology Europe19911714
     [Google Scholar]
  34. JenningV. Schäfer-KortingM. GohlaS. Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties.J. Control. Release2000662-311512610.1016/S0168‑3659(99)00223‑010742573
     [Google Scholar]
  35. ArunkumarN. DeecaramanM. RaniC. Nanosuspension technology and its applications in drug delivery.Asian J. Pharm.20093316810.4103/0973‑8398.56293
     [Google Scholar]
  36. JenningV. MäderK. GohlaS.H. Solid lipid nanoparticles (SLN™) based on binary mixtures of liquid and solid lipids: a 1H-NMR study.Int. J. Pharm.20002051-2152110.1016/S0378‑5173(00)00462‑211000538
     [Google Scholar]
  37. PerssonL.C. PorterC.J.H. CharmanW.N. BergströmC.A.S. Computational prediction of drug solubility in lipid based formulation excipients.Pharm. Res.201330123225323710.1007/s11095‑013‑1083‑723771564
     [Google Scholar]
  38. KarunakarG. PatelN.P. KamalS.S. Nano structured lipid carrier based drug delivery system.J. Chem. Pharm. Res.20168627643
     [Google Scholar]
  39. SoniK. KukerejaB.K. KapurM. KohliK. Lipid nanoparticles: future of oral drug delivery and their current trends and regulatory issues.Int J Curr Pharm Rev Res20157118
     [Google Scholar]
  40. kaurS. NautyalU. SinghR. SinghS. DeviA. Nanostructure Lipid Carrier (NLC): the new generation of lipid nanoparticles.Asian Pacific Journal of Health Sciences201522769310.21276/apjhs.2015.2.2.14
     [Google Scholar]
  41. MüllerR.H. MäderK. GohlaS. Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.Eur. J. Pharm. Biopharm.200050116117710.1016/S0939‑6411(00)00087‑410840199
     [Google Scholar]
  42. RuffoloS.A. La RussaM.F. MalagodiM. Oliviero RossiC. PalermoA.M. CrisciG.M. ZnO and ZnTiO3 nanopowders for antimicrobial stone coating.Appl. Phys., A Mater. Sci. Process.2010100382983410.1007/s00339‑010‑5658‑4
     [Google Scholar]
  43. KääriäinenM.L. KääriäinenT.O. CameronD.C. Titanium dioxide thin films, their structure and its effect on their photoactivity and photocatalytic properties.Thin Solid Films2009517246666667010.1016/j.tsf.2009.05.001
     [Google Scholar]
  44. KääriäinenM.L. CameronD.C. The importance of the majority carrier polarity and p-n junction in titanium dioxide films to their photoactivity and photocatalytic properties.Surf. Sci.20126063-4L22L2510.1016/j.susc.2011.11.009
     [Google Scholar]
  45. KääriäinenM.L. CameronD.C. Nitrogen doping in atomic layer deposition grown titanium dioxide films by using ammonium hydroxide.Thin Solid Films201252621221710.1016/j.tsf.2012.11.005
     [Google Scholar]
  46. SchillerR. WeissC.K. LandfesterK. Phase stability and photocatalytic activity of Zr-doped anatase synthesized in miniemulsion.Nanotechnology2010214040560310.1088/0957‑4484/21/40/40560320829575
     [Google Scholar]
  47. LoydV.A. Ansel’s pharmaceutical dosage forms, and drug delivery systems.9th edPhiladelphiaLippincott Williams & Will-DNS2011
     [Google Scholar]
  48. OfnerC.M. Encyclopedia of Pharmaceutical Technology.CRC Press200718751890
     [Google Scholar]
  49. GELS.Available from: https://slideplayer.com/slide/14349655/(accessed on 12-8-2024)
  50. KarandeP. MitragotriS. Enhancement of transdermal drug delivery via synergistic action of chemicals.Biochim. Biophys. Acta Biomembr.20091788112362237310.1016/j.bbamem.2009.08.01519733150
     [Google Scholar]
  51. PurohitD.K. NandgudeT.D. PoddarS.S. Nano-lipid carriers for topical application: Current scenario.Asian J. Pharm.20161019
     [Google Scholar]
  52. AshjaranA. NamayiA. Survey on nanofiber material as drug delivery systems.Res J Pharm BiolChem2014512621274
     [Google Scholar]
  53. DubeyA. PrabhuP. KamathJ.V. Nano structured lipid carriers: A novel topical drug delivery system.Int. J. Pharm. Tech. Res.20124705714
     [Google Scholar]
  54. BoardB.M.A. Reporting adverse drug reactions a guide for healthcare professionals.BMA Board Sci20066147158
     [Google Scholar]
  55. JoshiM. PatravaleV. Formulation and evaluation of Nanostructured Lipid Carrier (NLC)-based gel of Valdecoxib.Drug Dev. Ind. Pharm.200632891191810.1080/0363904060081467616954103
     [Google Scholar]
  56. EkambaramP. SathaliaA.H. PriyankaK. Solid Lipid Nanoparticles:A Review.Sci Rev ChemCommun2012280102
     [Google Scholar]
  57. OlivaresA.M. AlthoffK. ChenG.F. WuS. MorrissonM.A. DeAngelisM.M. HaiderN. Animal Models of Diabetic Retinopathy.Curr. Diab. Rep.201717109310.1007/s11892‑017‑0913‑028836097
     [Google Scholar]
  58. HansM.L. LowmanA.M. Biodegradable nanoparticles for drug delivery and targeting.Curr. Opin. Solid State Mater. Sci.20026431932710.1016/S1359‑0286(02)00117‑1
     [Google Scholar]
  59. JenningV. GohlaS. Comparison of wax and glyceride solid lipid nanoparticles (SLN®).Int. J. Pharm.2000196221922210.1016/S0378‑5173(99)00426‑310699722
     [Google Scholar]
  60. XiaQ. WangH. Preparation and characterization of coenzymesQ-10 loaded NLC.NSTI-Nanotech20103498501
     [Google Scholar]
  61. NaseriN. ValizadehH. Zakeri-MilaniP. Solid lipid nanoparticlesand nanostructured lipid carriers: Structure preparation and application.Adv. Pharm. Bull.20155330531310.15171/apb.2015.04326504751
     [Google Scholar]
  62. MoreauJ.W. WeberP.K. MartinM.C. GilbertB. HutcheonI.D. BanfieldJ.F. Extracellular proteins limit the dispersal of biogenic nanoparticles.Science200731658311600160310.1126/science.114106417569859
     [Google Scholar]
  63. PalS. TakY.K. SongJ.M. Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the Gram-negative bacterium Escherichia coli.Appl. Environ. Microbiol.20077361712172010.1128/AEM.02218‑0617261510
     [Google Scholar]
  64. FengQ.L. WuJ. ChenG.Q. CuiF.Z. KimT.N. KimJ.O. A mechanistic study of the antibacterial effect of silver ions onEscherichia coli andStaphylococcus aureus.J. Biomed. Mater. Res.200052466266810.1002/1097‑4636(20001215)52:4<662::AID‑JBM10>3.0.CO;2‑311033548
     [Google Scholar]
  65. FangJ.Y. FangC.L. LiuC.H. SuY.H. Lipid nanoparticles as vehicles for topical psoralen delivery: Solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC).Eur. J. Pharm. Biopharm.200870263364010.1016/j.ejpb.2008.05.00818577447
     [Google Scholar]
  66. CirriM. BragagniM. MenniN. MuraP. Development of a new delivery system consisting drug- in cyclodextrin- in nanostructured lipid carriers; for ketoprofen topical delivery.Eur. J. Pharm. Biopharm.2011324213221839833
     [Google Scholar]
  67. BabootaS. Al-AzakiA. KohliK. AliJ. DixitN. ShakeelF. Development and evaluation of a microemulsion formulation for transdermal delivery of terbinafine.PDA J. Pharm. Sci. Technol.200761427628517933209
     [Google Scholar]
  68. NayakA.N. MohantyB. SenK.K. Comparative evaluation of in vitro diclofenac sodium permeability across excised mouse skin from different common pharmaceutical vehicles.Int. J. Pharm. Tech. Res.201021920930
     [Google Scholar]
  69. PivettaT.P. SimõesS. AraújoM.M. CarvalhoT. ArrudaC. MarcatoP.D. Development of nanoparticles from natural lipids for topical delivery of thymol: Investigation of its anti-inflammatory properties.Colloids Surf. B Biointerfaces201816428129010.1016/j.colsurfb.2018.01.05329413607
     [Google Scholar]
  70. LeelapornpisidP. ChansakaowS. NaboonlongS. JantrawutP. Development of cream containing nanostructured lipid carrier loaded marigold flower extract for anti-wrinkle application.Int. J. Pharm. Pharm. Sci.20146313314
     [Google Scholar]
  71. CaonT. MazzarinoL. SimõesC.M.O. SennaE.L. SilvaM.A.S. Lipid- and polymer-based nanostructures for cutaneous delivery of curcumin.AAPS PharmSciTech201718392092510.1208/s12249‑016‑0554‑727230504
     [Google Scholar]
  72. IriventiP. GuptaN.V. Topical delivery of curcumin and caffeine mixture-loaded nanostructured lipid carriers for effective treatment of psoriasis.Pharmacogn. Mag.2020166820621710.4103/pm.pm_260_19
     [Google Scholar]
  73. ViegasJ.S.R. PraçaF.G. CaronA.L. SuzukiI. SilvestriniA.V.P. MedinaW.S.G. Del CiampoJ.O. KraviczM. BentleyM.V.L.B. Nanostructured lipid carrier co-delivering tacrolimus and TNF-α siRNA as an innovate approach to psoriasis.Drug Deliv. Transl. Res.202010364666010.1007/s13346‑020‑00723‑632060883
     [Google Scholar]
  74. JoshiM. PatravaleV. Nanostructured lipid carrier (NLC) based gel of celecoxib.Int. J. Pharm.20083461-212413210.1016/j.ijpharm.2007.05.06017651933
     [Google Scholar]
  75. KhalilR. ElbaryA. KassemM.A. RidyM.S. SamraM.M. AwadE.A. Formulation and characterization of nystatinloaded nanostructured lipid carriers for topical delivery against cutaneous candidiasis.Br. J. Pharm. Res.20144449051210.9734/BJPR/2014/7055
     [Google Scholar]
  76. HuF.Q. JiangS.P. DuY.Z. YuanH. YeY.Q. ZengS. Preparation and characteristics of monostearin nanostructured lipid carriers.Int. J. Pharm.20063141838910.1016/j.ijpharm.2006.01.04016563671
     [Google Scholar]
  77. BennettJ.E. Antimicrobial agents: Antifungal agents.Goodman & Gillman’s the Pharmacological Basis of Therapeutics.9th ed HardmanJ.G. LimbirdL.E. New York, NYMcGraw-Hill200111751190
     [Google Scholar]
  78. PhatakA.A. ChaudhariP.D. Development and evaluation of Nanostructured Lipid Carrier (NLC) based topical delivery of an anti-inflammatory drug.J. Pharm. Res.20137867768510.1016/j.jopr.2013.08.020
     [Google Scholar]
  79. MüllerR.H. RimplerC. PetersenR. HommossA. SchwabeK. A new dimension in cosmetic products by nanostructured lipid carriers (NLC) technology.Eurocosmetics2007153035
     [Google Scholar]
  80. AraújoJ. GonzalezE. EgeaM.A. GarciaM.L. SoutoE.B. Nanomedicines for ocular NSAIDs: safety on drug delivery.Nanomedicine20095439440110.1016/j.nano.2009.02.00319341814
     [Google Scholar]
  81. HanY. LiY. ZhangP. SunJ. LiX. SunX. KongF. Nanostructured lipid carriers as novel drug delivery system for lung cancer gene therapy.Pharm. Dev. Technol.201621327728110.3109/10837450.2014.99690025560648
     [Google Scholar]
  82. WangH. LiuS. JiaL. ChuF. ZhouY. HeZ. GuoM. ChenC. XuL. Nanostructured lipid carriers for MicroRNA delivery in tumor gene therapy.Cancer Cell Int.201818110110.1186/s12935‑018‑0596‑x30008618
     [Google Scholar]
/content/journals/pnt/10.2174/0122117385325593240820044758
Loading
Formulation Strategy and An Overview of Nano-Structured Lipid Carrier-Based Topical Gel as a Novel Drug Delivery System
Pharm. Nanotechnol. 13, 497 (2025); https://doi.org/10.2174/0122117385325593240820044758
/content/journals/pnt/10.2174/0122117385325593240820044758
/content/journals/pnt/10.2174/0122117385325593240820044758
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): Colloidal carrier system; liquid lipid; manufacturing techniques; NLCs; solid lipid; stability of formulation

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test